Microfluidics or lab-on-a-chip (LOC) 4 diagnostic devices have the potential to provide fast, laboratory-quality results to expedite clinical decisions at various point-ofcare (POC) settings, including outpatient clinics, emergency rooms, and intensive care units (1 ). Unfortunately, these technologies remain out of reach in the developing world, where lack of access to quality diagnoses contributes to the enormous burden of disease (2 ).
The Smartphone Dongle
In an exemplary demonstration of the new generation of POC diagnostic tools, Laksanasopin et al. (4 ) described an LOC-based smartphone accessory ("dongle") that is tailor-made for resource-limited settings (Fig. 1) . The dongle is capable of carrying out immunoassays on disposable plastic cassettes preloaded with plugs of reagents and wash buffer and immobilized with disease-specific antigens. Through immunorecognition, antibody markers in the sample are captured by the antigens on the plastic surface and then detected using secondary antibodies labeled with gold nanoparticles. Finally, analyte binding events are transduced and amplified through silver reduction onto the nanoparticles. The fluid handling in the cassette relies on a hand-powered "1-push vacuum" mechanism, which generates the negative pressure required to move the sample and reagents through the device. The other components of the dongle, including light-emitting diodes, photodiodes, and microcontroller, are powered through the audio jack (from the smartphone), which also serves as the conduit for data transmission. Because the dongle consumes very little power, an audio jack interface with a smartphone is sufficient to provide power for at least 41 assays on a single charge. The manufacturing cost of the dongle is US $34.
The new device was evaluated in Rwanda by a team of healthcare workers who were previously unfamiliar with the technology. To guide the workers through each test, the smartphone used to control the device is equipped with an app that provides step-by-step directions and built-in timers. After an initial training period of 30 min, the healthcare workers tested fresh fingerprick whole blood from 96 patients whose disease status was not revealed until the conclusion of the test. The cassettes were prepackaged with reagents appropriate to detect anti-HIV as well as treponemal and nontreponemal (i.e., cardiolipin) tests for syphilis, and each triplex test required 15 min and US $1.44 in materials. The performance of the dongle rivaled laboratory-based testing, with sensitivity and specificity of 100% and 87% for HIV, 92% and 92% for treponemal syphilis, and 100% and 79% for nontreponemal syphilis. In a survey carried out after the tests, the vast majority (97%) of the participants preferred the dongle method to conventional laboratory tests (requiring venous blood draw) because of the fast turnaround time, multiplexing capability, lower amount of blood required, and simplicity of the method.
Laksanasopin et al. (4 ) demonstrate, quite convincingly, that smartphone technology and thoughtful system integration can help improve diagnosis, making it faster and cheaper without compromising the quality of the test. We believe that this study sets the pace for the next generation of diagnostic devices for the developing world.
Implications for the Practice of Clinical Chemistry
Peer-reviewed publications about new diagnostic devices are exciting, but these innovations will not have impact unless they can be widely distributed and used (3 ) . With the increasing adoption of smartphones in the developing world, leveraging their capabilities for POC testing may be a game-changing strategy to deliver laboratory-quality LOC diagnostics in resource-limited settings. The cost and complexity of LOC diagnostic devices can be substantially reduced when functions such as detection, power source, and data processing are outsourced to a smartphone (4 ) . A smartphone interface can provide users with a familiar platform to acquire, visualize, and upload diagnostic data. In addition, the marriage of smartphones and diagnostics may be able to expand the reach of existing healthcare delivery systems, making it straightforward to give wireless counseling, conduct disease surveillance, receive external quality assurance, and provide decision support to healthcare workers in remote locations (3 ) .
Not surprisingly, more researchers are beginning to use smartphones in their next-generation LOC diagnostic prototypes. The new devices often include a 3D-printed enclosure that houses a smartphone, off-the-shelf electronic/optical components, and microfabricated assay elements. For example, by use of a smartphone for detection, along with micropatterning (5 ) for multiplexing, multiple disease biomarkers for hepatitis C virus can be detected in a resource-limited setting. As LOC diagnostic tests mature and become more widely used, their adoption in the developing world will increase (as with the mobile phone), and ultimately, the next generation of tests may help reduce the enormous burden caused by infectious and noncommunicable diseases every year. 
